|
|
|
|
| LEADER |
00000nab a2200000 a 4500 |
| 001 |
vtls009090309 |
| 003 |
SK-MaSNL |
| 005 |
20260304214815.0 |
| 008 |
140303c2007 xo wrzp 0 0slo |
| 015 |
|
|
|a SNBRB2007/08
|2 snkbucl
|
| 040 |
|
|
|a SNKBUCL
|b slo
|c SNKBUCL
|e AACR2
|
| 041 |
0 |
|
|a slo
|
| 044 |
|
|
|a xo
|c SK
|
| 080 |
|
|
|a 616.379-008.64-085:061.3
|x (437.6)
|2 1997
|
| 080 |
|
|
|a 616.12:616.379-008.64
|2 1997
|
| 080 |
|
|
|a 615.272.03
|2 1997
|
| 100 |
1 |
|
|a Bánska, Katarína
|4 aut
|9 122208
|
| 245 |
1 |
0 |
|a Kardiovaskulárne kontinuum
|c Katarína Bánska
|
| 300 |
|
|
|a Fotogr.
|
| 611 |
2 |
7 |
|a Diabetologické dni
|n (17. :
|d 2007 :
|c Martin, Slovensko)
|2 snkbucl
|9 1061291
|
| 650 |
0 |
7 |
|a diabetes mellitus
|2 SNKPH
|9 72741
|
| 650 |
0 |
7 |
|a dyslipidémia
|2 SNKPH
|9 15386
|
| 650 |
0 |
7 |
|a odborné podujatia
|2 SNKPH
|9 839632
|
| 650 |
0 |
7 |
|a hypertenzia
|2 SNKPH
|9 2490
|
| 650 |
0 |
7 |
|a fluvastatín
|2 SNK
|9 842210
|
| 650 |
0 |
7 |
|a Lescol XL
|2 SNK
|9 1548897
|
| 650 |
0 |
7 |
|a kardiovaskulárne riziká
|2 SNK
|9 105572
|
| 650 |
0 |
7 |
|a farmakoterapia
|2 SNKPH
|9 14158
|
| 650 |
0 |
7 |
|a farmakológia
|2 SNKPH
|9 2468
|
| 650 |
0 |
7 |
|a terapia
|2 SNKPH
|9 781
|
| 773 |
0 |
|
|t Zdravotnícke noviny
|g Roč. XII, č. 26 (2007)
|x 1335-4477
|
| 773 |
0 |
8 |
|t Kompendium medicíny
|g Č. 7 (2007), s.44-49
|
| 852 |
|
|
|a SNK
|b KIS3GCP
|
| 958 |
|
|
|a MI
|
| 958 |
|
|
|a SK
|
| 999 |
|
|
|c 3143357
|d 3145287
|
